121 related articles for article (PubMed ID: 31038363)
1. Clinical efficacy and safety of paclitaxel liposomes as first-line chemotherapy in advanced gastric cancer.
Han G; Shi J; Mi L; Li N; Shi H; Li C; Shan B; Yin F
Future Oncol; 2019 May; 15(14):1617-1627. PubMed ID: 31038363
[No Abstract] [Full Text] [Related]
2. Clinical comparison between paclitaxel liposome (Lipusu®) and paclitaxel for treatment of patients with metastatic gastric cancer.
Xu X; Wang L; Xu HQ; Huang XE; Qian YD; Xiang J
Asian Pac J Cancer Prev; 2013; 14(4):2591-4. PubMed ID: 23725180
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
Wan Y; Hui H; Wang X; Wu J; Sun S
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the therapeutic effects of paclitaxel liposome-5-Fu versus paclitaxel-5-Fu on 67 patients with advanced gastric cancer].
Wu F; Chen SC; Lu ZH; Xiong JP
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):234-6. PubMed ID: 20450596
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel/oxaliplatin/fluorouracil (TOF) regimen versus S-1/oxaliplatin (SOX) regimen for metastatic gastric cancer patients.
Dai X; Zhang X; Wang C; Jiang J; Wu C
Oncotarget; 2017 May; 8(18):30495-30501. PubMed ID: 27911869
[TBL] [Abstract][Full Text] [Related]
6. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
[TBL] [Abstract][Full Text] [Related]
7. Effect of the weekly administration of liposome-Paclitaxel combined with s-1 on advanced gastric cancer.
Chen L; Chen Q; Zhuang Z; Zhang Y; Tao J; Shen L; Shen X; Chen Z; Wang J; Zhu M; Wang H
Jpn J Clin Oncol; 2014 Mar; 44(3):208-13. PubMed ID: 24453274
[TBL] [Abstract][Full Text] [Related]
8. Effects of paclitaxel liposome and capecitabine in the treatment of advanced gastric cancer by clinical observation.
Lu M; Wang T; Wang J
Int J Clin Pharmacol Ther; 2016 Sep; 54(9):693-7. PubMed ID: 27390051
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-based regimens as first-line treatment in advanced gastric cancer.
Guo Z; Wang X; Lin R; Chen L; Fan N; Chen Y; Lin J; Yu J
J Chemother; 2015 Feb; 27(2):94-8. PubMed ID: 24548091
[TBL] [Abstract][Full Text] [Related]
10. The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY).
Tanioka H; Nagasaka T; Uno F; Inoue M; Okita H; Katata Y; Kanzaki H; Kuramochi H; Satake H; Shindo Y; Doi A; Nasu J; Yamashita H; Yamaguchi Y
BMC Cancer; 2019 Oct; 19(1):941. PubMed ID: 31604467
[TBL] [Abstract][Full Text] [Related]
11. Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial.
Bang YJ; Xu RH; Chin K; Lee KW; Park SH; Rha SY; Shen L; Qin S; Xu N; Im SA; Locker G; Rowe P; Shi X; Hodgson D; Liu YZ; Boku N
Lancet Oncol; 2017 Dec; 18(12):1637-1651. PubMed ID: 29103871
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel, safe, and effective regimen.
Murad AM; Petroianu A; Guimaraes RC; Aragao BC; Cabral LO; Scalabrini-Neto AO
Am J Clin Oncol; 1999 Dec; 22(6):580-6. PubMed ID: 10597742
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer.
Jiang H; Qian J; Zhao P; Zhang X; Zheng Y; Mao C; Zheng Y; Chen L; Wang Y; Mou H; Fang W; Teng L; Xu N
Cancer Chemother Pharmacol; 2015 Jul; 76(1):197-203. PubMed ID: 26013324
[TBL] [Abstract][Full Text] [Related]
14. Combination Chemotherapy with S-1 and Oxaliplatin (SOX) as First-Line Treatment in Elderly Patients with Advanced Gastric Cancer.
Zhong DT; Wu RP; Wang XL; Huang XB; Lin MX; Lan YQ; Chen Q
Pathol Oncol Res; 2015 Sep; 21(4):867-73. PubMed ID: 25648439
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with paclitaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer.
Lan YQ; Kong LJ; Lin XY; Xu Q; Gao XY; Wu RP; Wang XL; Zhong DT
Cancer Chemother Pharmacol; 2018 Jun; 81(6):1007-1015. PubMed ID: 29619507
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and side effect analysis of paclitaxel liposome for neoadjuvant chemotherapy in locally advanced cervical cancer].
Wang YT; Li B; Li XG; Ma SK; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):588-594. PubMed ID: 31550774
[No Abstract] [Full Text] [Related]
17. [A clinical study of paclitaxel combined with FOLFOX4 regimen as neoadjuvant chemotherapy for advanced gastric cancer].
Qu JJ; Shi YR; Liu FR; Ma SQ; Ma FY
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Sep; 13(9):664-7. PubMed ID: 20878572
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer.
Bando H; Shimodaira H; Fujitani K; Takashima A; Yamaguchi K; Nakayama N; Takahashi T; Oki E; Azuma M; Nishina T; Hironaka S; Komatsu Y; Shitara K
Eur J Cancer; 2018 Mar; 91():86-91. PubMed ID: 29353164
[TBL] [Abstract][Full Text] [Related]
19. [A randomized controlled trail of taxol-based combination regimens for advanced gastric cancer].
Yang JW; Chen YG; Chen Q; Fan NF; Guo ZQ; Cai XC; Wu XA; Xu S; Lu X; Zhang YH; Ouyang XN
Ai Zheng; 2005 Dec; 24(12):1531-6. PubMed ID: 16351808
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel combined with oxaliplatin as first-line chemotherapy for locally advanced or metastatic gastric cancer.
Shi C; Chen Q; Shen S; Wu R; Yang B; Liu Q; Xu Q
Expert Rev Anticancer Ther; 2015 May; 15(5):595-601. PubMed ID: 25827975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
